Friday, 03 May 2024
Onconova Therapeutics Inc.
01:44 | 19/3/18
Macon Daily
Onconova Therapeutics Inc logo ValuEngine upgraded shares of Onconova Therapeutics (NASDAQ:ONTX) from a sell rating to a hold rating in a research note issued to investors on Wednesday morning.
more»
03:37 | 15/3/18
Post Analyst
Sanofi (NYSE:SNY) current P/S is an impressive 2.27. The overall Drug Manufacturers - Major group has an average P/S ratio of 6.15, which is significantly better than the sector's 8.74.
more»
06:15 | 11/3/18
Frisco Fastball
Analysts expect Onconova Therapeutics, Inc. (NASDAQ:ONTX) to report $-0.71 EPS on March, 26.They anticipate $0.17 EPS change or 31.48 % from last quarter's $-0.54 EPS.
more»
01:00 | 9/3/18
GlobeNewswire
With no FDA approved therapies available for patients with higher-risk MDS who are refractory to hypomethylating agents, Onconova has taken a leadership position in this indication. Looking ahead, we now expect topline analysis to be concurrent with ...
more»
00:26 | 9/3/18
Simply Wall St
Onconova Therapeutics Inc's (NASDAQ:ONTX): Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer.
more»
02:30 | 7/3/18
GlobeNewswire
NEWTOWN, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on ...
more»
01:56 | 6/3/18
GlobeNewswire
NEWTOWN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic ...
more»
05:52 | 2/3/18
GlobeNewswire
NEWTOWN, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic ...
more»
04:22 | 27/2/18
Street Observer
Onconova Therapeutics, Inc. (ONTX) stock price traded with surging change along with the volume 0.31 million shares on Friday trading session.
more»
00:48 | 27/2/18
Post Analyst
T2 Biosystems, Inc. (NASDAQ:TTOO) recent rally took place on significantly more volume which surged nearly 0.34 million contracts on 23-Feb-18 versus its daily average of 0.26 million.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |